SCHEMBL7526149

SCHEMBL7526149

Cn1cc(C2=C(c3cn(C)c4cc(N5CCOCC5)ccc34)C(=O)NC2=O)c2ccc(C#N)cc21

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 11/20 0.53
ALK Q9UM73 3/20 0.49
PRKCB P05771 5/20 0.45
PRKCA P17252 5/20 0.45
PRKCE Q02156 3/20 0.45
PRKCG P05129 6/20 0.44
PRKCD Q05655 1/20 0.44
BRD4 O60885 1/20 0.44
CREBBP Q92793 1/20 0.44
CDK2 P24941 2/20 0.44
CCNE2 O96020 1/20 0.44
CDK4 P11802 1/20 0.44
CCND1 P24385 1/20 0.44
CCNE1 P24864 1/20 0.44
CDK1 P06493 1/20 0.43
PRKCQ Q04759 1/20 0.43
KIT P10721 1/20 0.42
KDR P35968 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7525540 0.91 ALK (0.49) GSK3BALKBRD4CREBBPCDK2
SCHEMBL7977136 0.85 GSK3B (0.57) GSK3BPRKCBPRKCAPRKCEPRKCG
SCHEMBL7530443 0.85 GSK3B (0.72) GSK3BPRKCBPRKCAPRKCEPRKCG
SCHEMBL7976571 0.85 GSK3B (0.56) GSK3BPRKCBPRKCAPRKCEPRKCG
SCHEMBL7976147 0.85 GSK3B (0.56) GSK3BPRKCBPRKCAPRKCEPRKCG
SCHEMBL7976579 0.85 GSK3B (0.56) GSK3BPRKCBPRKCAPRKCEPRKCG
SCHEMBL7976484 0.83 GSK3B (0.54) GSK3BPRKCBPRKCAPRKCEPRKCG
SCHEMBL7987080 0.82 GSK3B (0.54) GSK3BPRKCBPRKCAPRKCEPRKCG
SCHEMBL7976559 0.81 GSK3B (0.53) GSK3BPRKCBPRKCAPRKCEPRKCG
SCHEMBL7990615 0.81 BRD4 (0.43) GSK3BALKBRD4CREBBPKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US claimed
EP-1242409-A2 SUBSTITUTED BISINDOLYLMALEIMIDES F. HOFFMANN-LA ROCHE AG (CH) 2002-09-25 EP disclosed
US-6281356-B1 ANTICANRCER AGENTS HOFFMANN-LA ROCHE INC. 2001-08-28 US disclosed
WO-2001046178-A2 SUBSTITUIERTE BISINDOLYMALEIMIDE F. HOFFMANN-LA ROCHE AG (CH) 2001-06-28 WO disclosed